A pilot study of single pegfilgrastim compared with intermittent every other days of 5 shot-filgrastim in breast cancer patients receiving adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy (G-CSF 105 trial: NCT02685111)

Authors :: Kyung Hwa Jung
H.S. Lee
Byeong Seok Sohn
Kwan Sik Lee
Ji-Eun Kim
S.-B. Kim
Joohyuk Sohn
J-H Ahn
S-J Koh
Ji Seon Oh
Jae Hong Seo
Joseph Jeong
Source :: Annals of Oncology. 29:ix5
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
Chemotherapy
Cyclophosphamide
business.industry
medicine.medical_treatment
Hematology
Filgrastim
medicine.disease
Chemotherapy regimen
Granulocyte colony-stimulating factor
Breast cancer
Docetaxel
Internal medicine
medicine
business
Pegfilgrastim
medicine.drug

Full Text Access

Tools